C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2011
12/27/2011	US8084219 Methods for detecting and analyzing N-glycolylneuraminic acid (Neu5Gc) in biological materials
12/27/2011	US8084204 Displacement assay for detection of small molecules
12/27/2011	US8084200 Compositions and methods for the diagnosis and treatment of tumor
12/27/2011	US8084033 Composition comprising a cell expressing an AC133 cell surface antigen and an antibody or antigen-binding fragment
12/27/2011	US8084032 Protein A chromatography; desorption via arginine and/or derivative thereof
12/27/2011	US8084031 Method for the treatment of inflammatory disorders
12/27/2011	US8084030 Method of treating a patient having an autoimmune disorder by administering an antibody that binds human BCMA
12/27/2011	US8084029 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
12/27/2011	US8084028 Antibodies to VLA-1
12/27/2011	US8084026 Multispecific binding molecules comprising connecting peptides
12/27/2011	US8084020 Use of anti-CD1 antibodies for the modulation of immune responses
12/25/2011	CA2708753A1 Peptide diagnostic agent for lyme disease
12/22/2011	WO2011160083A1 Antibodies useful in passive influenza immuization
12/22/2011	WO2011160078A2 Use of camelid-derived variable heavy chain variable regions targeting cd18 and icam-1 as a microbicide to prevent hiv-1 transmission
12/22/2011	WO2011160023A1 Immunogenic compositions derived from structural alteration of hiv envelope proteins
12/22/2011	WO2011159980A1 Anti-axl antibodies and methods of use
12/22/2011	WO2011159938A2 High affinity human antibodies to human cytomegalovirus (cmv) gb protein
12/22/2011	WO2011159928A2 Anti-dr4 agonist antibodies
12/22/2011	WO2011159847A2 Receptor tyrosine kinase-like orphan receptor 1 (ror1) single chain fv antibody fragment conjugates and methods of use thereof
12/22/2011	WO2011159835A1 Antibodies to endoplasmin and their use
12/22/2011	WO2011159741A2 Tetranor-pgem/pgam specific immunogens, antibodies, tracers, assay kits and methods for making same
12/22/2011	WO2011159735A2 Tetranor-pgdm/pgjm specific immunogens, antibodies, tracers, assay kits and methods for making same
12/22/2011	WO2011159704A1 Anti-vegf antibodies and uses thereof
12/22/2011	WO2011159000A1 Human monoclonal antibody that binds specifically with oxidized low-density lipoprotein and carbamylated low-density lipoprotein, and antigen-binding fragment thereof
12/22/2011	WO2011158973A1 Novel antifibrin antibody
12/22/2011	WO2011158883A1 Antibody capable of determination of cancer prognosis, and cancer prognosis determination method
12/22/2011	WO2011158122A2 Anti-human equilibrative nucleoside transporter 1 (hent1) antibodies and methods of use thereof
12/22/2011	WO2011158019A1 Polypeptide vaccine
12/22/2011	WO2011158009A1 Animal models and therapeutic molecules
12/22/2011	WO2011157905A1 Polyclonal antibody binding to acetylated hmgb1
12/22/2011	WO2011157741A2 Human antibody drug conjugates against tissue factor
12/22/2011	WO2011157724A1 S100a4 antibodies and therapeutic uses thereof
12/22/2011	WO2011157447A2 Modified parvovirus having enhanced anti-tumour efficacy
12/22/2011	WO2011157275A1 Modulation of the interaction between sorla and gdnf-family ligand receptors
12/22/2011	WO2011133886A3 Production of heteromultimeric proteins
12/22/2011	WO2011131787A3 Antibody preparations
12/22/2011	WO2011131786A3 Process for preparing an immunoglobulin composition
12/22/2011	WO2011101328A3 Treatment with a humanized igg class anti egfr antibody and an antibody against insulin like growth factor 1 receptor
12/22/2011	WO2011094467A3 Methods of treating diabetes with dll4 antagonists
12/22/2011	WO2011085057A3 Methods for detecting insulin autoantibody
12/22/2011	WO2011081421A3 Complement c9 as markers for the diagnosis of cancer
12/22/2011	US20110313681 Biomarkers for peripheral artery disease
12/22/2011	US20110313139 Method for polyclonal immunoglobulin g production by human b cells
12/22/2011	US20110313138 Method for Producing Proteins
12/22/2011	US20110313137 Her2 antibody compositions
12/22/2011	US20110313136 IgG-Fc FRAGMENT AND PROCESS FOR PRODUCING THE SAME
12/22/2011	US20110313135 Recombinant Monovalent Antibodies
12/22/2011	US20110313134 Engineered antibodies with reduced immunogenicity and methods of making
12/22/2011	US20110313130 Bifunctional chelating agents
12/22/2011	US20110313129 Large stokes shift dyes
12/22/2011	US20110313029 Diagnostic and therapeutic uses of gnptab, gnptg, and nagpa in stuttering
12/22/2011	US20110313026 Dna and proteins or peptides specific of bacteria of the neisseria meningitidis species, methods for obtaining them and biological applications thereof
12/22/2011	US20110312893 Method for isolating neural cells with tenascin-r compounds
12/22/2011	US20110312533 CELL LINES EXPRESSING NaV AND METHODS OF USING THEM
12/22/2011	US20110312514 Method For Determination And Quantification Of Radiation Or Genotoxin Exposure
12/22/2011	US20110312505 Rapid Isolation of Monoclonal Antibodies from Animals
12/22/2011	US20110312105 Detection system and method for high sensitivity fluorescent assays
12/22/2011	US20110311999 Diagnostic prediction of rheumatoid arthritis and systemic lupus erythematosus
12/22/2011	US20110311990 Tetranor-pgem/pgam specific immunogens, antibodies, tracers, assay kits and methods for making same
12/22/2011	US20110311989 Antibody to n-terminal region of hemoglobin beta-chain
12/22/2011	US20110311612 Humanized Neuraminidase Antibody and Methods of Use Thereof
12/22/2011	US20110311569 HIV-1 Peptides, Nucleic Acids, and Compositions and Uses Thereof
12/22/2011	US20110311560 Methods and Compositions Relating to CCR5 Antagonist, IFN-Gamma and IL-13 Induced Inflammation
12/22/2011	US20110311559 Method of identifying cd4+ cd25+ t-cells activated to an antigen which express cd8
12/22/2011	US20110311556 Anti-rhesus d monoclonal antibody
12/22/2011	US20110311555 Tc11 as a Transcriptional Regulator
12/22/2011	US20110311553 Effectors of PAR-2 Activation and Their Use in the Modulation of Inflammation
12/22/2011	US20110311552 Notch1 receptor binding agents and methods of use thereof
12/22/2011	US20110311551 Antibodies directed against hepatitis c virus e1e2 complex, compositions of hcv particles, and pharmaceutical compositions
12/22/2011	US20110311550 Agents for hcv treatment
12/22/2011	US20110311546 Angiopoietin-2 specific binding agents
12/22/2011	US20110311544 Anti-cd71 Monoclonal Antibodies and Uses Thereof for Treating Malignant Tumor Cells
12/22/2011	US20110311543 Tumor Antigens BFA5 for Prevention and/or Treatment of Cancer
12/22/2011	US20110311542 Sp35 Antibodies and Uses Thereof
12/22/2011	US20110311541 Mutant proteins of the f protein of piv-5 and piv-2
12/22/2011	US20110311540 Wisp polypeptides and nucleic acids encoding same
12/22/2011	US20110311539 Diagnosis and treatment of cancer using cancer-testis antigens
12/22/2011	US20110311538 Inhibitors of receptor tyrosine kinases and methods of use thereof
12/22/2011	US20110311531 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/22/2011	US20110311530 Truncated baff receptors
12/22/2011	US20110311526 Polynucleotide and polypeptide sequences involved in the process of bone remodeling
12/22/2011	US20110311522 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof
12/22/2011	US20110311521 Novel therapy for anxiety
12/22/2011	US20110311520 Methods for treatment of allergic asthma
12/22/2011	US20110311517 Antibodies and methods for treating estrogen receptor-associated diseases
12/22/2011	US20110311516 Chemically Programmed Vaccination
12/22/2011	US20110311454 Molecules with extended half-lives, compositions and uses thereof
12/22/2011	US20110311450 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
12/22/2011	US20110311449 Antibodies
12/22/2011	US20110311448 Antibody to rage and uses for in vivo imaging or for targeting therapy
12/22/2011	US20110311443 Pharmaceutical composition and method for identifying a cancerous and/or an inflammatory disease in a patient
12/22/2011	DE102010024636A1 New antibody, preferably monoclonal antibody, which is interacted with carcinoembryonic antigen cell adhesion molecule-1 protein, useful for the specific or selective determination and/or detection of CEACAM1 protein in a sample
12/22/2011	CA2839421A1 Antibodies useful in passive influenza immuization
12/22/2011	CA2839420A1 High affinity human antibodies to human cytomegalovirus (cmv) gb protein
12/22/2011	CA2802868A1 Methods and systems for generating, validating and using monoclonal antibodies
12/22/2011	CA2802857A1 Antibodies to endoplasmin and their use
12/22/2011	CA2802782A1 Human antibody drug conjugates against tissue factor
12/22/2011	CA2802631A1 S100a4 antibodies and therapeutic uses thereof
12/22/2011	CA2802599A1 Modified parvovirus having enhanced anti-tumour efficacy
12/22/2011	CA2802591A1 Animal models and therapeutic molecules

1 ... 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 ... 1494